Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes
- PMID: 12936704
- DOI: 10.1080/0049825031000121608
Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes
Abstract
1. The aim was to identify the cytochrome P450 (CYP) enzymes responsible for the N-demethylation of morphine in vitro. 2. In human liver microsomes, normorphine formation followed Michaelis-Menten kinetics with mean Km and Vmax of 12.4 +/- 2.2 mM and 1546 +/- 121 pmol min(-1) mg(-1), respectively. In microsomes from a panel of 14 human livers phenotyped for 10 CYP enzymes, morphine N-demethylation correlated with testosterone 6beta-hydroxylation (r=0.91, p<0.001) and paclitaxel 6-alpha hydroxylation (r=0.72, p<0.001), two specific markers of CYP3A4 and CYP2C8, respectively. Normorphine formation decreased when incubated in the presence of troleandomycin or quercetin (by 46 and 33-36%, respectively), which further corroborates the contribution of CYP3A4 and CYP2C8. 3. Among eight recombinant human CYP enzymes tested, CYP3A4 and CYP2C8 exhibited the highest intrinsic clearance. More than 90% of morphine N-demethylation could be accounted for via the action of both CYP3A4 and CYP2C8. 4. The in vitro findings suggest that hepatic CYP3A4, and to a lesser extent CYP2C8, play an important role in the metabolism of morphine into normorphine.
Similar articles
-
In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation.Drug Metab Dispos. 2003 Jun;31(6):748-54. doi: 10.1124/dmd.31.6.748. Drug Metab Dispos. 2003. PMID: 12756207
-
CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.Br J Clin Pharmacol. 2003 Sep;56(3):305-14. doi: 10.1046/j.0306-5251.2003.01862.x. Br J Clin Pharmacol. 2003. PMID: 12919179 Free PMC article.
-
Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin.Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):249-56. doi: 10.1111/j.1742-7843.2005.pto_157.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16176562
-
Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.Eur J Clin Pharmacol. 2004 May;60(3):173-82. doi: 10.1007/s00228-004-0740-5. Epub 2004 Mar 31. Eur J Clin Pharmacol. 2004. PMID: 15054565
-
Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes.Br J Pharmacol. 2010 Nov;161(5):1059-69. doi: 10.1111/j.1476-5381.2010.00946.x. Br J Pharmacol. 2010. PMID: 20977456 Free PMC article.
Cited by
-
The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine.Int J Legal Med. 2018 Mar;132(2):415-424. doi: 10.1007/s00414-017-1754-8. Epub 2017 Dec 1. Int J Legal Med. 2018. PMID: 29196879
-
Candidate gene polymorphisms predicting individual sensitivity to opioids.Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):269-81. doi: 10.1007/s00210-007-0205-3. Epub 2007 Nov 13. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 17999051 Review.
-
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.Drug Metab Dispos. 2011 Sep;39(9):1589-96. doi: 10.1124/dmd.111.038588. Epub 2011 Jun 17. Drug Metab Dispos. 2011. PMID: 21685245 Free PMC article.
-
Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles.Pharm Biol. 2022 Dec;60(1):1-8. doi: 10.1080/13880209.2021.2005636. Pharm Biol. 2022. PMID: 34860644 Free PMC article.
-
Opioid metabolism.Mayo Clin Proc. 2009 Jul;84(7):613-24. doi: 10.1016/S0025-6196(11)60750-7. Mayo Clin Proc. 2009. PMID: 19567715 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous